Designing of Coumarin molecules as EGFR inhibitors and their ADMET, MD Simulation Studies for Evaluating potential as Anticancer molecules
- 31 March 2024
- journal article
- research article
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 17 (3) , 1008-1014
Abstract
Breast cancer has been predicted to impact over 2.3 million women annually, with 685,000 deaths occurring out of this condition globally. Breast cancer initially appears in the epithelial cells of channels or lobules of breast glandular tissue whereas less commonly from the basal cells outer layer. Even though some inhibitors have demonstrated anti-breast cancer cell activity, resistance to existing inhibitors and their severe side effects have forced to develop new derivatives. Coumarin nucleoside derivatives were therefore studied in silico, and their effectiveness against cancer cells was found. The studies consisted of ADMET properties, target prediction, MD stimulation, and drug-likeliness characterises. Out of the 12 compounds studied, compounds 2 and 4 were found most potent with binding energy (-7.091 and -7.018kcal/mol respectively). The standard erlotinib (AQ4) with a binding energy of -8.614 kcal/mol.Keywords
This publication has 13 references indexed in Scilit:
- Exosome and Breast CancerResearch Journal of Pharmacy and Technology, 2022
- Computational Docking Technique for Drug Discovery: A ReviewResearch Journal of Pharmacy and Technology, 2021
- Design, Synthesis and Antibacterial, Antifungal Activity of Some Coumarin Acetohydrazide DerivativesResearch Journal of Pharmacy and Technology, 2021
- Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancerMedicine, 2020
- Application of Nanotechnology for Cancer Treatment2018
- Nanocarrier Based Anticancer Drug Delivery System: Current Trends and ProspectsResearch Journal of Pharmacy and Technology, 2017
- Synthesis and Antimicrobial Evaluation of Some Novel Derivatives of Coumarin MoietyResearch Journal of Pharmacy and Technology, 2016
- Immunotherapy for the Treatment of Breast CancerCurrent Oncology Reports, 2015
- In silico Docking Approach of Coumarin Derivatives as an Aromatase AntagonistResearch Journal of Pharmacy and Technology, 2015
- Cognitive Function and Reproductive Hormones in Adjuvant Therapy for Breast CancerJournal of Pain and Symptom Management, 2001